## FRSH: Freshworks Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -0.2% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($11.79)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | BTIG | $0 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | BTIG | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($3.99M) |
| Sells | 11 ($1.26M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 328.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 4 |

**Top Holders:**
- Vanguard Group Inc: 75.2% (-0.8%)
- Blackrock Inc.: 49.9% (-1.4%)
- Alphabet Inc.: 46.3% (0.0%)
- Westbridge Capital M: 38.2% (0.0%)
- Peak XV Partners Ope: 31.0% (-7.4%)

### Key Risks

1. Long-term trend broken: trading 5.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.59 indicates undervaluation relative to growth. Forward P/E 18.3x stretched relative to 8% growth. Balance sheet: strong liquidity (2.3x). Insider buying signal ($4.0M), management confidence. Institutional flow bullish (4 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $3.7B |
| Beta | 0.89 |
| 52W Range | $10.51 - $19.77 |
| Short Interest | 6.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.59 |
| Forward P/E | 18.3 |
| Current P/E | 19.9 |
| YoY Growth | 8.4% |
| EPS Direction | RISING |

### Technicals

MRS_20 weakening modestly (-0.8% over 5 days). Below STRENGTH zone by 4.2pp (needs >4.0% for momentum thesis). Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 55. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.16% (CS: 44) | Neutral |
| RSI_14 | 54.6 | Neutral |
| MACD Histogram | -0.06 | Bearish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 1.065x | Above |
| vs SMA200 | 0.941x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $12.61
- **Stop Loss:** $11.79 (6.5% risk)
- **Target:** $13.43 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1463
- **Position Value:** $18,448.43
- **Portfolio %:** 18.45%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-10 (Est: $0.11)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.13 | $0.16 | +25.4% |
| 2025Q2 | $0.11 | $0.18 | +57.8% |
| 2025Q1 | $0.13 | $0.18 | +39.4% |
| 2024Q4 | $0.10 | $0.14 | +37.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*